Vanberra Signal
Free trial

Asimov

Curated by Signal

AI-based computer-aided designing tool for drug discovery

Health Technologyasimov.com

Overview

AI-based computer-aided designing tool for drug discovery. The company has designed a mammalian cell engineering platform that can design drugs for manufacturing and gene therapy. It comes with features like synthetic biology, docking, multi-omics measurement, and more.

Key facts

Founded
2017
Headquarters
Boston, United States
Stage
Sign up to view
Industry
Health Technology

Business model

5 products and services
Sign up to view
Commercial model
Sign up to view

Open roles

3 roles

  • Research Associate, DNA & Strain Construction (Contractor)

    Boston, MA · On-site · Contract

  • Senior Software Engineer

    Boston, MA · On-site · Full-time

  • Senior Software Engineer

    Boulder, CO · On-site · Full-time

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Changes For Life

    Online platform offering a variety of integrated health and wellness services

    Health TechnologyBohemia, United States

  • Green Journal

    Journaling app for cannabis users to track their experiences and preferences

    Health TechnologyUnited States

  • Instant Care

    Pendant with automatic fall detection system for elderly

    Health TechnologyEscondido, United States

About Asimov

What does Asimov do?

AI-based computer-aided designing tool for drug discovery.

Where is Asimov headquartered?

Asimov is headquartered in Boston, United States.

When was Asimov founded?

Asimov was founded in 2017.

Which sector is Asimov in?

Asimov operates in Health Technology.

Who are Asimov's competitors?

Companies similar to Asimov include Changes For Life, Green Journal, and Instant Care.

Is Asimov hiring?

Yes. Asimov has 3 open roles listed on Vanberra Signal.